Protective role of indomethacin on lipopolysaccharide-stimulated fever induction and cerebral catecholamine biosynthesis in Wistar rat

Neuroendocrinology Letters

Volumn 33, Issue 7, 2012, Pages 713-721

  Adham, Khadiga G ^a,b   Al Humaidhi, Eman M H ^c   Daghestani, Maha H ^a   Aleisa, Nadia A ^a   Farhood, Manal H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Alexandria University Faculty Of Science   (Egypt)

^c PRINCESS NOURAH BINT ABDULRAHMAN UNIVERSITY   (Saudi Arabia)

Author keywords

Cerebellum; Cerebral cortex; Dopamine; Indomethacin; Lipopolysachharide; Medulla; Midbrain; Norepinephrine; Pons; Rectal temperature; Thalamus hypothalamus

Indexed keywords

CATECHOLAMINE; DOPAMINE; INDOMETACIN; LIPOPOLYSACCHARIDE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; FEVER; MALE; NONHUMAN; OBSERVATIONAL STUDY; PONS; PROSTAGLANDIN SYNTHESIS; RAT;

EID: 84874724161     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Ajmone-Cat M, Bernardo A, Greco A and Minghetti L (2010). Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions. Pharmaceuticals. 3: 1949-1964.
2. Antony SA, Gudluru S, Pal B, Vadivelan R, Kumar MNS, Elango K and Suresh B (2010). Indomethacin, nifedipine and its combination produced anti-parkinson's activity in 6- OHDA lesioned rat model. Int. J. Compr. Pharmacy. 1(4): 1-3.
3. Beishuizen A. and Thijs LG (2003). Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. Innate Immunity. 9: 3-24. (Pubitemid 36322480)
4. Blatteis CM, Sehic E and Li S (2000). Complement and the pathogenesis of endotoxic fever. Int J. Biometeorol. 43: 176-183. (Pubitemid 129563561)
5. Brandtzaeg P (1996). Significance and pathogenesis of septic shock. Curr. Top. Microbiol. Immunol. 216: 15-37.
6. Castaño A, Herrera AJ, Cano J and Machado A (2002). The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J. Neurochem. 81: 150-157. (Pubitemid 34808862)
7. Chang CC (1964). A sensitive method for spectrofluorometric assay of catecholamines. Int. J. Neuropharmacol. 3: 643-649.
8. Ciarlone AE (1978). Further modification of a fluorometric method for analyzing brain amines. Microchemical J. 23: 9-12.
9. Clark WG and Cumby HR (1975). The antipyretic effect of indomethacin. J. Physiol. 248(3): 625-38.
10. Coceani F, Bishai I, Lees J and Sirko S (1989). Prostaglandin E2 in the pathogenesis of pyrogen fever: validation of an intermediary role. In: Advances in Prostaglandin, Thrmoboxane and Leukotriene Research, (B. Samuelsson, P.Y-K. Wong, and F. F. Sun, eds), Raven Press, New York, 19, pp. 394-397.
11. Dairam A, Antunes EM, Saravanan KS and Daya S (2006). Non-steroidal anti-inflammatory agents, tolmetin and sulindac, inhibit liver tryptophan 2,3-dioxygenase activity and alter brain neurotransmitter levels. Life Sci. 79: 2269-2274. (Pubitemid 44666067)
12. DeVries HE, Blom-Roosemalen MC, De Boer AG, Van Berkel TJ, Breimer DD and Kuiper J (1996). Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro. J. Pharmacol. Exp. Ther. 277: 1418-1423. (Pubitemid 27167154)
13. Dinarello CA, Bodel PT and Atkins E (1968). The role of the liver in the production of fever and in pyrogenic tolerance. Trans Assoc. Am. Physicians. 81: 334-344.
14. Dunn AJ (1992). Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: Comparison with interleukin-1. J. Pharmacol. Exp. Ther. 261: 964-969.
15. Ek M, Kurosawa M, Lundeberg T and Ericsson A (1998). Activation of vagal afferents after intravenous injection of interleukin-1β: role of endogenous prostaglandins. J. Neurosci. 18: 9471-9479. (Pubitemid 28512476)
16. Elmquist JK, Scammell TE, Jacobson CD and Saper CB (1996). Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J. Comp. Neurol. 371: 85-103.
17. Fan H and Cook JA (2004). Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10: 71-84.
18. Ferreira SH, Moncada S and Vane JR (1971). Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biol. 231: 237-239.
19. Flierl MA, Rittirsch D, Nadeau BA, Sarma JV, Day DE, Alex B, Lentsch AB, Huber-Lang MS and Ward PA (2009). Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS ONE 4(2): e4414.
20. th ed., edited by B.G. Katzung, Appleton and Lange, Connecticut, pp. 304-318.
21. Francis J, MohanKumar SM and MohanKumar PS (2000). Correlations of norepinephrine release in the paraventricular nucleus with plasma corticosterone and leptin after systemic lipopolysaccharide: blockade by soluble IL-1 receptor. Brain Res. 867: 180-187.
22. Glowinski J and Iversen LL (1966). Regional studies of catecholamines in the rat brain. I. The disposition of [3H]-norepinephrine. C3H]-dopamine and C3H]-DOPA in various regions of the brain. J. Neurochem. 13: 655-669.
23. Goppelt-Strube M (1995). Regulation of prostaglandin endoperoxidase synthase (cyclo-oxygenase) isozyme expression. Prostaglandins Leukot. Essent. Fatty Acids. 52(4): 213-22.
24. Guth L (2012). A reassessment of LPS/Indomethacin/Pregnenolone combination therapy after spinal cord injury in rats. Exp. Neurol. 233(2): 686.
25. Hassanein NM, Hasan WA and Hamed MR (2004). Effects of diclofenac, Piroxicam and alpha-tocopherol on monoamine lymphopoietic interfacing in mice. Arzneimittelforschung. 54: 847-856. (Pubitemid 39657682)
26. Jansky L, Vybiral S, Pospisilova D, Roth J, Dornand J, Zeisberger E and Kaminkova J (1995). Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology. 62: 55-61.
27. Kimura A, Sakurada S, Ohkuni H, Todome Y and Kurata K (2002). Moderate hypothermia delays proinflammatory cytokine production of human peripheral blood mononuclear cells. Crit. Care Med. 30: 1499-1502. (Pubitemid 34756231)
28. Kozak W, Chesy G, Kadziela W, Caputa M and Lachowski A (1985). Arylsulphatase A and acid phosphatae activities in plasma and leucocytes during LPS fever in the ox (Bos taurus). Comp. Biochem. Physiol. A Comp. Physiol. 81(1): 165-169.
29. Kozak W, Conn CA and Kluger MJ (1994). Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. Am. J. Physiol. 266: 125-135.
30. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS and Smithies O (1995). Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83: 483-492.
31. Lavicky J, Dunn AJ (1995). Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis. J. Neurosci. Res. 40: 407-413.
32. Li Z and Blatteis CM (2004). Fever onset is linked to the appearance of lipopolysaccharide in the liver. J. Endotoxin Res. 10: 1-15.
33. Liang NY, Hower JA and Borchardt RT (1985). Release of endogenous brain epinephrine by calcium ionophores X537A and A2317. Brain Res. 341: 297-302. (Pubitemid 15246298)
34. Linthorst ACE and Reul JMHM (1998). Brain neurotransmission during peripheral inflammation. Ann. N. Y. Acad. Sci. 840: 139-152. (Pubitemid 28302045)
35. Linthorst ACE, Flachskamm C, Holsboer F and Reul JMHM (1996). Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: Involvement of the cyclo-oxygenase pathway. Neuroscience. 72: 989-997.
36. Masana MI, Heyes MP, Mefford IN (1990). Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge. Prog. Neuropsychopharmacol. Biol. Psychiat. 14(4): 609-621. (Pubitemid 20272352)
37. Mohamed MI, Aly MS, Hussein RM and Hassan WA (2004). Effect of bacterial endotoxin on the levels of monoamines in different tissues of rat. Egypt. J. Biochem. 22: 262-286.
38. Mohamed MI, Aly MS, Hussein RM and Hassan WA (2005). Protective effect of two anti-inflammatory drugs against the changes of monoamine levels induced by bacterial endotoxin in rat brain. Egypt. J. Pharm. 2: 675-696.
39. Molina-Holgado F and Guaza C (1996). Endotoxin administration induced differential neurochemical activation of the rat brain stem nuclei. Brain Res. Bull. 40(3): 151-6. (Pubitemid 26166682)
40. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE and Ognibene FP (1990). Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113: 227-242. (Pubitemid 20242299)
41. Perlik V, Li Z, Goorha S, Bailou LR and Blatteis CM (2005). Lipopolysaccharide (LPS)-activated complement, not LPS per se, triggers the early release of PGE2 by Kupffer cells. Am. J Physiol. Regul. Integr. Comp. Physiol. 289: 332-339.
42. Pirnes-Karhu S, Sironen R, Alhonen L. and Uimari A (2012). Lipopolysaccharide-induced anti-inflammatory acute phase response is enhanced in spermidine/spermine N1-acetyltransferase (SSAT) overexpressing mice. Amino Acids. 42(2-3): 473-84.
43. Raetz CRH and Whitfield C (2002). Lipopolysaccharide Endotoxins, Annu. Rev. Biochem. 71: 635-700. (Pubitemid 34800232)
44. Romanovsky AA, Kulchitsky VA, Akulich NV, Koulchitsky SV, Simons CT, Sessler DI and Gourine VN (1996). First and second phases of biphasic fever: two sequential stages of the sickness syndrome. Am. J. Physiol. 271: 244-253.
45. Ruiter DJ, van der Meulen J, Brouwer A, Hummel MJR, Mauw BJ, van der Ploeg JCM and Wisse E (1981). Uptake by liver cells of endotoxin following its intravenous injection. Lab. Invest. 45: 38-45. (Pubitemid 11059989)
46. Scammell TE, Griffin JD, Elmquist JK and Saper CB (1998). Microinjection of a cyclooxygenase inhibitor into the anteroventral preoptic region attenuates LPS fever. Am. J. Physiol. 274: R783-789.
47. Segal M, Deneau GA and Seevers MH (1972). Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys. Neuropharmacology 11(2): 211-222.
48. Shimizu N, Hori T and Nakane H (1994). An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats. Brain Behav. Immun. 8: 14-23. (Pubitemid 24163517)
49. Simons CT, Kulchitsky VA, Sugimoto N, Homer LD, Szekely M and Romanovsky AA (1998). Signaling the brain in systemic inflammation: which vagal branch is involved in fever genesis? Am. J. Physiol. Regul. Integr. Comp. Physiol. 275: 63-68.
50. Sternberg EM (2006). Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6: 318-328.
51. Szelényi J and Vizi ES (2007). The catecholamine-cytokine balance: Interaction between the brain and the immune system. Ann. NY. Acad. Sci. 1113: 311-324. (Pubitemid 350015022)
52. Taylor KM and Snyder SH (1970). Amphetamine: differentiation by d and I isomers of behavior involving brain Norepinephrine or dopamine. Science. 168: 1487-1489.
53. Vane JR (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirinelike drugs. Nat. New Biol. 231(25): 232-235.
54. Vogt M (1954). The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. Lond. 123: 451-481.
55. Wang S, Yan JY, Lo YK, Carvey PM and Ling Z (2009). Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res. 1265: 196-204.
56. Wang V, Chia LG, Ni DR, Cheng LJ, Ho YP, Cheng FC and Hong JS (2004). Effects of the combined treatment of naloxone and indomethacin on catecholamines and behavior after intranigral lipopolysaccharide injection. Neurochem. Res. 29(2): 341-6. (Pubitemid 38223014)
57. Watkins LR, Goehler LE, Relton JK, Tartaglia N, Silbert L, Martin D and Maier SF (1995). Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci. Lett. 183: 27-31.